The Precision Medicine Era of Bronchiectasis

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2024 Jul 1

PMID 38949497

Authors

Sanjay H Chotirmall

James D Chalmers

Affiliations

Soon will be listed here.

Citing Articles

Artificial Intelligence Unveils the Unseen: Mapping Novel Lung Patterns in Bronchiectasis via Texture Analysis.

Nair A, Mohan R, Greeshma M, Benny D, Patil V, Madhunapantula S Diagnostics (Basel). 2025; 14(24.

PMID: 39767244 PMC: 11675828. DOI: 10.3390/diagnostics14242883.

Targeting neutrophil serine proteases in bronchiectasis.

Chalmers J, Mall M, Chotirmall S, ODonnell A, Flume P, Hasegawa N Eur Respir J. 2024; 65(1).

PMID: 39467608 PMC: 11694565. DOI: 10.1183/13993003.01050-2024.

References

Dhar R, Singh S, Talwar D, Mohan M, Tripathi S, Swarnakar R . Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health. 2019; 7(9):e1269-e1279. DOI: 10.1016/S2214-109X(19)30327-4. View

Tiew P, Thng K, Chotirmall S . Clinical Signatures in COPD and Bronchiectasis. J Fungi (Basel). 2022; 8(5). PMC: 9146266. DOI: 10.3390/jof8050480. View

Poh T, Tiew P, Hou Lim A, Thng K, Ali N, Narayana J . Increased Chitotriosidase Is Associated With Aspergillus and Frequent Exacerbations in South-East Asian Patients With Bronchiectasis. Chest. 2020; 158(2):512-522. DOI: 10.1016/j.chest.2020.02.048. View

Vidaillac C, Chotirmall S . in bronchiectasis: infection, inflammation, and therapies. Expert Rev Respir Med. 2021; 15(5):649-662. DOI: 10.1080/17476348.2021.1906225. View

Aliberti S, Masefield S, Polverino E, Soyza A, Loebinger M, Menendez R . Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. Eur Respir J. 2016; 48(3):632-47. DOI: 10.1183/13993003.01888-2015. View

Aliberti S, Sotgiu G, Blasi F, Saderi L, Posadas T, Garcia M . Blood eosinophils predict inhaled fluticasone response in bronchiectasis. Eur Respir J. 2020; 56(2). DOI: 10.1183/13993003.00453-2020. View

Mac Aogain M, Ivan F, Jaggi T, Richardson H, Shoemark A, Narayana J . Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis. Am J Respir Crit Care Med. 2024; 210(1):47-62. PMC: 11197066. DOI: 10.1164/rccm.202306-1059OC. View

Narayana J, Mac Aogain M, Goh W, Xia K, Tsaneva-Atanasova K, Chotirmall S . Mathematical-based microbiome analytics for clinical translation. Comput Struct Biotechnol J. 2021; 19:6272-6281. PMC: 8637001. DOI: 10.1016/j.csbj.2021.11.029. View

Mac Aogain M, Lau K, Cai Z, Narayana J, Purbojati R, Drautz-Moses D . Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease. Am J Respir Crit Care Med. 2020; 202(3):433-447. PMC: 7397787. DOI: 10.1164/rccm.201911-2202OC. View

10.

Kurz S, Zha B, Herman D, Holt M, Daley C, Ruminjo J . Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease. Ann Am Thorac Soc. 2020; 17(9):1033-1039. DOI: 10.1513/AnnalsATS.202003-222CME. View

11.

Oriano M, Amati F, Gramegna A, Soyza A, Mantero M, Sibila O . Protease-Antiprotease Imbalance in Bronchiectasis. Int J Mol Sci. 2021; 22(11). PMC: 8199509. DOI: 10.3390/ijms22115996. View

12.

Shteinberg M, Nassrallah N, Jrbashyan J, Uri N, Stein N, Adir Y . Upper airway involvement in bronchiectasis is marked by early onset and allergic features. ERJ Open Res. 2018; 4(1). PMC: 5773814. DOI: 10.1183/23120541.00115-2017. View

13.

Barnes P . Endo-phenotyping of COPD patients. Expert Rev Respir Med. 2020; 15(1):27-37. DOI: 10.1080/17476348.2020.1804364. View

14.

Chotirmall S, Chalmers J . Bronchiectasis: an emerging global epidemic. BMC Pulm Med. 2018; 18(1):76. PMC: 5963022. DOI: 10.1186/s12890-018-0629-1. View

15.

Bhatt S, Agusti A, Bafadhel M, Christenson S, Bon J, Donaldson G . Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2023; 208(10):1026-1041. PMC: 10867924. DOI: 10.1164/rccm.202209-1748SO. View

16.

Casey M, Gabillard-Lefort C, McElvaney O, McElvaney O, Carroll T, Heeney R . Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis. Thorax. 2023; 78(8):835-839. DOI: 10.1136/thorax-2022-219943. View

17.

Dicker A, Lonergan M, Keir H, Smith A, Pollock J, Finch S . The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021; 9(8):885-896. DOI: 10.1016/S2213-2600(20)30557-9. View

18.

Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M . Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023; 11(7):637-649. DOI: 10.1016/S2213-2600(23)00093-0. View

19.

Finch S, Shoemark A, Dicker A, Keir H, Smith A, Ong S . Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis. Am J Respir Crit Care Med. 2019; 200(8):992-1001. PMC: 6794104. DOI: 10.1164/rccm.201812-2351OC. View

20.

Rademacher J, Konwert S, Fuge J, Dettmer S, Welte T, Ringshausen F . Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J. 2019; 55(1). DOI: 10.1183/13993003.01333-2019. View